Skip to content
ppharmaranks
Menu

LEVO-DROMORAN vs VANTRELA ER

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 16, 2026·How we rate

Possible drug interaction. LEVO-DROMORAN and VANTRELA ER are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Rating

70/100
New

Pharmacy pays

~$319.37 /30
~$239.83 /30

Type

RX
RX

Active ingredient

LEVORPHANOL TARTRATE
HYDROCODONE BITARTRATE

Dosage forms

Injectable, Tablet
Tablet, extended release

Drug class

Opioid Agonist
Opioid Agonist

Boxed warning

None
None

Half-life

about 3.8 hours (3.8 ± 0.3 hours)

Treats

Pain
Cough, Obstructive Lung Diseases, Postoperative Pain

Frequently asked questions

Which is cheaper, Levo-Dromoran or Vantrela ER?

Vantrela ER costs pharmacies less to acquire — about $239.83 vs $319.37 for a 30-count supply, per the CMS NADAC survey. That gap is in the pharmacy's cost of goods, not necessarily in what you pay: your price is set afterwards by your insurer and the pharmacy.

What is the difference between Levo-Dromoran and Vantrela ER?

Levo-Dromoran contains Levorphanol Tartrate, while Vantrela ER contains Hydrocodone Bitartrate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.